A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

A booming gray market is turning kitchens into makeshift pharmacies as Americans chase cheaper alternatives to high-priced ...

New guidance helps GPs manage patients using privately obtained weight-loss injections, addressing gaps in support like ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

In the M-ACCEL trial, HU6-induced weight loss was exclusively attributed to fat loss, with no statistically significant loss ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...

The GLP-1 drugs, including Mounjaro and Wegovy, work by mimicking the action of hormones that make you feel full, while ...

Dr Willie told Reach: “You should speak to your doctor about any conditions or medications before taking any weight loss ...

Hims & Hers extended its rally for the second day on Friday, adding 6.76 percent to close at $49.41 apiece after its chief ...

OZEMPIC-PENIS sounds like a sexually transmitted disease you really wouldn’t want to catch. But it’s actually a term that has cropped up online, largely amongst men on Reddit, who are saying ...

Thousands are now eligible to get Mounjaro through the NHS, but some may need to avoid it and it might not even work for ...